Click or scroll to zoom
Tap or pinch to zoom
Abrysvo RSV Vaccine (Respiratory Syncytial Virus Vaccine) 0.5 mL Kit (Rx) **Refrigerated Item
by Pfizer USPG
Save 28%
Original price
$ 675.00
Current price
$ 485.00
SKU 00069-0344-01
Medical Professional License Required to Unlock Account
(Note: We don’t Fill Personal Prescriptions)
How to Order:
(Note: We don’t Fill Personal Prescriptions)
How to Order:
✔
Create an Account by Clicking “Login” on Top Right
✔
Next email a copy of medical License to Sales@mountainside-medical.com
✔
Time: License Approval in Usually Very Fast. Mostly likely 30 to 90 minutes if between Monday to Friday 8 am to
4 pm EST Business Days. Weekends will be approved on Monday.
✔
Once Approved you will receive a Welcome email that your account is approved to purchase RX items.
✔ Login and Start ordering.
✔If you should have any trouble or have a question, Please Call Toll-Free: 1-888-687-4334
✔All RX Deliveries are sent Signature Required
The RSV Vaccine is used as a preventative measure against the Respiratory Syncytial Virus (RSV). This family of viruses is one of the leading causes of respiratory diseases and can affect infants, young children and the elderly. By vaccinating against the virus it helps to reduce the risk of infants and young children from contracting the virus. Studies show that by introducing the RSV Vaccine in contexts such as Day Care Centres, community health centers, and homes for the elderly the risk of the virus being spread is dramatically lowered. Immunization with the RSV Vaccine boosts the immune system’s effectiveness at fighting off the virus and obtaining herd immunity from the virus.
The Abrysvo RSV Vaccine (Respiratory Syncytial Virus Vaccine) 0.5 mL Kit is a medical breakthrough, which can help protect individuals from multiple illnesses, including respiratory syncytial virus (RSV) infection. It is an injectable vaccine of 0.5 mL dosage, based on a validated (inactivated) recombinant canarypox virus (ALVAC) vector and a formalin inactivated RSV virus-like particle (VLPTM-E48E) antigen. The vaccine has two components–the primary dose at four weeks and a to booster dose at eight or nine weeks–protecting vulnerable families from an array of serious wellness complications. It offers an effective immunization for infants and young children, strengthening their natural defenses against ovecome the potentially dangerous virus and other consequences, since RSVchild's most common and troubling causes of lower respiratory flow involve in hospitalization in developing countries. Sourcepy disease.
ABRYSVO is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. Administer a single dose (approximately 0.5 mL) of ABRYSVO intramuscula
The Abrysvo RSV Vaccine (Respiratory Syncytial Virus Vaccine) 0.5 mL Kit is a medical breakthrough, which can help protect individuals from multiple illnesses, including respiratory syncytial virus (RSV) infection. It is an injectable vaccine of 0.5 mL dosage, based on a validated (inactivated) recombinant canarypox virus (ALVAC) vector and a formalin inactivated RSV virus-like particle (VLPTM-E48E) antigen. The vaccine has two components–the primary dose at four weeks and a to booster dose at eight or nine weeks–protecting vulnerable families from an array of serious wellness complications. It offers an effective immunization for infants and young children, strengthening their natural defenses against ovecome the potentially dangerous virus and other consequences, since RSVchild's most common and troubling causes of lower respiratory flow involve in hospitalization in developing countries. Sourcepy disease.
ABRYSVO is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. Administer a single dose (approximately 0.5 mL) of ABRYSVO intramuscula
